HCA logo

HCA HEALTHCARE INC

HCANYSE
πŸ† #160 by market capUS Equity
$427.67β–Ό $5.09 (βˆ’1.19%)
Live
πŸ””
Track HCA
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 1.2%
7dβ–Ό 2.4%
14dβ–² 1.0%
30dβ–² 2.3%
ytdβ–Ό 8.3%
1yβ–² 1.6%
🏦Market Cap
$92.59B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+7.3%
Slowing
πŸ“ŠGross Margin
85.3%
High
πŸ’΅FCF Margin
7.7%
Moderate
βš–οΈP/S Ratio
1.2x
Cheap
Otter Score
52
Weak

Trading Snapshot

Day Range
$424.67 – $433.33
52-Week Range
$353.99 – $556.52
Volume
$2.45B
Avg Volume
$2.12B
Shares Outstanding
216.5M
Next Earnings
Nov 27, 2026

Fundamentals Snapshot

Annual Revenue
$75.60B
Last Q Revenue
$20.23B
P/E Ratio
13.7
P/S Ratio
1.2x
EPS (TTM)
$29.87
Dividend Yield
0.73%
Dilution (1yr)
βˆ’9.6%

Why Investors Own HCA

  • βœ“High-growth profile β€” revenue up +3.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 40% gross margin and 15% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

HCA logo

HCA HEALTHCARE INC

HCA
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$75.6Bβ–² +7.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
41.5%β–² +2.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$12.0Bβ–² +13.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$7.7Bβ–² +36.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
230.7Mβ–Ό βˆ’9.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$49.2Bβ–Ό βˆ’$5.9B YoY
StockOtter Β· stockotter.space

About HCA HEALTHCARE INC

HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
52/100

Analyst Price Target

β“˜
Average Target
$500.61
β–² +17.1% Upside
High Target$603.67
Low Target$438.59
Based on 19 analysts

Latest News & Updates